Fantastic work/leadership Margaret Foti, PhD, MD (hc) wonderful to see you in Seattle! Fred Hutchinson Cancer Center Dr. Tom Lynch Binaytara Foundation Binay Shah, MD, MHA Umang Swami Dipesh Uprety MD FACP Jorge Cortes MD Congrats to Ulka Vaishampayan for the award!
Inspired to contribute to elimination of disparities globally! Julie Gralow

So grateful to & proud of the amazing young philanthropists & advocates at Sigma Chi Fraternity !!! You absolutely rock!! Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE 🇺🇸 Huntsman Cancer Institute

Happy to share our editorial recently published in Cancer Cell ! Grateful for terrific mentorship from Neeraj Agarwal, MD, FASCO and team Umang Swami Benjamin L Maughan Georges Gebrael GU Cancer Research Program @HuntsmanCancer 👉tinyurl.com/48px5rw8👇👇

Just in Cancer Cell 👉Validation of the molecular clusters of the IMmotion151 trial in the JAVELIN Renal 101 dataset #kidneycancer : Excellent commentary highlighting these biomarkers by our fellow Chadi Hage Chehade 👇tinyurl.com/48px5rw8 GU Cancer Research Program @HuntsmanCancer OncoAlert UroToday.com KidneyCAN

Manisha Bhattacharya and Aaron Goodman - “Papa Heme” leading the debate on “Is Universal Healthcare a Solution to US Healthcare Disparities?” Binaytara Foundation #SCHD24

Great to see Dipesh Uprety MD FACP Anish K. Shah Umang Swami Jorge Cortes MD at great gala organised by Binaytara Foundation Binay Shah, MD, MHA supporting a new cancer center in Nepal!Inspiring cause to help patients with cancer & reduce disparities!Fantastic to see Margaret Foti, PhD, MD (hc) & chat about @AACR #AACR24

How do non-DDR genomic alterations influence management of patients with advanced #prostatecancer . Presented by Ana Aparicio MD Anderson Cancer Center. #APCCC24 Written coverage by Rashid K. Sayyid Univ of Toronto Urology. > bit.ly/4besNsu Advanced Prostate Cancer Consensus Conference

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉 majority of panelist favor offering Lutetium-177 RLT Rx after ARPI and docetaxel Rx in mCRPC #prostatecancer 👇 OncoAlert PCF Science

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉 most panelists favor continuing Lutetium-177 RLT Rx to complete 6 cycles even after PSA/clinical/radiological response after 4 cycles in mCRPC #prostatecancer OncoAlert PCF Science silke gillessen

Advanced Prostate Cancer Consensus Conference OncoAlert PCF Science silke gillessen #APCCC24 Advanced Prostate Cancer Consensus Conference 👉 majority of panelists favored retreating pts with mCRPC #prostatecancer with lutetium-177 RLT Rx if they had response to previous Lutetium-177 Rx lasting for more than 6 months OncoAlert PCF Science

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉 brilliant talk by Michael Hofman 👉Current gallium and fluorinated PSMA diagnostic tracers are equivalent & current PSMA radiologist therapies (PSMA-617 & PSMA I&T)seem radio-equivalent👇OncoAlert PCF Science silke gillessen

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉 How to monitor and manage toxicities with Lutetium-177 PSMA RLT? #LuisEmmett 👉adaptive dosing based on SPECT scan results may improve toxicity, & rule out disease progression before assuming marrow toxicity👇OncoAlert PCF Science

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉 Andrew Armstrong ‘s comprehensive talk on emerging Rx options in neuro-endocrine #prostatecancer 👉Lurbinectedin, CXCR2i, DLL3i and other potential Rx strategies👇OncoAlert PCF Science UroToday.com

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉Excellent talk by Heather H. Cheng on who should undergo germ line testing?👉ongoing neoadjuvant trials in germline mutation+ #prostatecancer and take home message👇OncoAlert PCF Science silke gillessen

Ana Aparicio How do non-DDR genomic alterations influence management of patients with advanced prostate cancer?🧬🩸
⭕️ Prospective marker-selected or marker-stratified studies to validate the predictive value of other non-HRD genomic alterations are needed.

#APCCC24

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉 How to select mCRPC pts #ProstateCancer for lutetium-177 RLT therapy ?👉excellent talk by Thomas Hope 👉select pts based on ⬆️uptake than liver, post-Rx SPECT (+conventional scans) & not PSMA-PET should be done to follow pts👇 OncoAlert PCF Science

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉Ana Aparicio ‘s excellent perspective on how to interpret clinical genomic tests👇 and framework for drug development in advanced #prostatecancer & highlights ongoing SWOG Cancer Research Network 2312 trial OncoAlert PCF Science

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Brilliant discussion on the use of social /digital media & AI to improve disparities in #prostatecancer care by Stacy Loeb, MD NYU Langone Health 👉 Inexpensive ways to raise awareness & access among patients & providers OncoAlert silke gillessen Oncology Brothers

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 outstanding talk by the super star Vedang Murthy from Tata Memorial Hospital , Mumbai 👉challenges faced by oncology docs in India & solutions👉Simplify care, improve access, & remarkable advances in telemedicine 👇OncoAlert silke gillessen NationalCancerGrid

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Rising incidence and mortality with #prostatecancer in Africa👉key will be to improve early detection (most diagnosed and biopsies through digital exam), improve access to radiotherapy, develop local Rx guidelines👇 OncoAlert Abeid Athman PCF Science